- Home
- NUVB vs IE Comparison
NUVB vs IE Comparison
Compare NUVB & IE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUVB
- IE
- Stock Information
- Founded
- NUVB 2018
- IE 2020
- Country
- NUVB United States
- IE United States
- Employees
- NUVB N/A
- IE N/A
- Industry
- NUVB Biotechnology: Pharmaceutical Preparations
- IE Metal Mining
- Sector
- NUVB Health Care
- IE Basic Materials
- Exchange
- NUVB Nasdaq
- IE Nasdaq
- Market Cap
- NUVB 679.9M
- IE 745.0M
- IPO Year
- NUVB N/A
- IE 2022
- Fundamental
- Price
- NUVB $2.23
- IE $6.27
- Analyst Decision
- NUVB Strong Buy
- IE Strong Buy
- Analyst Count
- NUVB 5
- IE 3
- Target Price
- NUVB $8.20
- IE $12.17
- AVG Volume (30 Days)
- NUVB 3.3M
- IE 1.0M
- Earning Date
- NUVB 05-07-2025
- IE 05-07-2025
- Dividend Yield
- NUVB N/A
- IE N/A
- EPS Growth
- NUVB N/A
- IE N/A
- EPS
- NUVB N/A
- IE N/A
- Revenue
- NUVB $7,873,000.00
- IE $2,901,000.00
- Revenue This Year
- NUVB $75.73
- IE $64.50
- Revenue Next Year
- NUVB $440.21
- IE $0.73
- P/E Ratio
- NUVB N/A
- IE N/A
- Revenue Growth
- NUVB N/A
- IE N/A
- 52 Week Low
- NUVB $1.54
- IE $4.50
- 52 Week High
- NUVB $3.97
- IE $12.98
- Technical
- Relative Strength Index (RSI)
- NUVB 61.24
- IE 51.79
- Support Level
- NUVB $2.10
- IE $6.35
- Resistance Level
- NUVB $2.22
- IE $6.80
- Average True Range (ATR)
- NUVB 0.14
- IE 0.42
- MACD
- NUVB 0.04
- IE 0.08
- Stochastic Oscillator
- NUVB 90.25
- IE 70.05
About NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).
About IE Ivanhoe Electric Inc.
Ivanhoe Electric Inc is a United States-based d minerals exploration company with a focus on developing mines from mineral deposits principally located in the United States. The company has four business segments; Santa Cruz Project; critical metals; data processing services; and energy storage. It derives a majority of its revenue from Canada. The Santa Cruz Project and critical metals segments are focused on mineral project exploration and development. The data processing segment provides data analytics, geophysical modeling, and artificial intelligence services for the mineral, oil & gas, and water exploration industries. The energy storage segment develops, manufactures, and installs vanadium flow batteries for grid-scale energy storage.